Zeo ScientifiX (ZEOX) Convertible Debt (2018 - 2025)
Zeo ScientifiX (ZEOX) posted Convertible Debt of $41667.0 for Q4 2025, down 70.02% on a QoQ basis from $139000.0 in Q1 2022.
Powered by 
Analysis
Zeo ScientifiX (ZEOX) Convertible Debt (2018 - 2025) Analysis & Trends
Zeo ScientifiX has reported Convertible Debt for 4 years, with the latest figure at $41667.0 in Q4 2025.
- On a quarterly basis, Convertible Debt changed N/A year-over-year to $41667.0 in Q4 2025; TTM through Oct 2025 was $41667.0, a N/A change from a year earlier, with the FY2025 full-year figure at $41667.0, changed N/A from the prior year.
- Convertible Debt was $41667.0 for Q4 2025 at Zeo ScientifiX, down from $139000.0 in the prior quarter.
- The five-year high for Convertible Debt was $139000.0 in Q1 2022, with the low at $41667.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Zeo ScientifiX | 8.53 Mn | 6.69 Mn | 2.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Oct 31, 2025 | 41,667.00 |
| Jan 31, 2022 | 139,000.00 |
| Oct 31, 2020 | 175,000.00 |
| Jul 31, 2020 | 150,000.00 |
| Apr 30, 2020 | 150,000.00 |
| Jan 31, 2020 | 150,000.00 |
| Jul 31, 2018 | 150,000.00 |